Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01753037 · ClinicalTrials.gov registry record · NA
Effects of Androgen Administration on Inflammation in Normal Women
A NA study of Hyperandrogenism, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
- 1
- Study location
NCT01753037: Completed NA study of Hyperandrogenism, sponsored by Mayo Clinic.
NCT01753037 is a NA study of Hyperandrogenism that has completed, run by Mayo Clinic. The registered enrollment target is 25 participants, below the 33-participant average among 3 other Hyperandrogenism trials with a reported enrollment target (24% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01753037, a NA study of Hyperandrogenism, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
The hypothesis of this study is that DHEA administration to increase male hormone in healthy normal-weight young women to levels present in women with Polycystic Ovary Syndrome will cause an inflammatory response in white blood cells in the fasting state, and in response to glucose ingestion.
Primary Outcome
White blood cell NFkappaB activation will be assessed in response to glucose ingestion before and after 5 days of DHEA or placebo administration.
Conditions Studied
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT Dehydroepiandrosterone (DHEA)
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2006-12 |
| Est. Completion | 2010-04 |
| Phase | NA |
What the finished NCT01753037 record still lists
NCT01753037 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 33-participant average among 3 other Hyperandrogenism trials with a reported enrollment target (24% lower).
The record links to 1 condition, with Hyperandrogenism appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT01753037 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT01753037 about?
NCT01753037 is a clinical study titled "Effects of Androgen Administration on Inflammation in Normal Women". The hypothesis of this study is that DHEA administration to increase male hormone in healthy normal-weight young women to levels present in women with Polycystic Ovary Syndrome will cause an inflammatory response in white blood cells in the fasting state, and in response to glucose ingestion.
What is the current status of trial NCT01753037?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2006-12. Estimated completion is 2010-04.
What conditions does trial NCT01753037 study?
This clinical trial studies the following conditions: Hyperandrogenism.
What interventions are being tested in trial NCT01753037?
The interventions under investigation include: Placebo (OTHER), Dehydroepiandrosterone (DHEA) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01753037?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01753037 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hyperandrogenism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Does Spironolactone Normalize Sleep-wake Luteinizing Hormone Pulse Frequency in Pubertal Girls With Hyperandrogenism?
RECRUITING · Early Phase 1
-
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
RECRUITING · Early Phase 1
-
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
RECRUITING · Early Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia